カテゴリー： QYResearch, 世界, 医療/バイオ

アリピプラゾールAPIのグローバル市場2023年：純度≧99%、純度＜99%

◆英語タイトル：Global Aripiprazole API Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8680）◆商品コード：QYR23MA8680
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：93
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のアリピプラゾールAPI市場について調査・分析し、世界のアリピプラゾールAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度＜99%）、用途別セグメント分析（錠剤、内服液、ODT、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Teva、APOTEX、SMS Pharmaceutical、Otsuka Pharmaceutical、Bal Pharma、Huahai Pharmaceutical、Jiuzhou Pharmaceutical、Qilu Pharmaceutical、Yangtze River Pharmaceutical、Kanghong Pharmaceutical、Yongtai Pharmaceuticalなどが含まれています。世界のアリピプラゾールAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、アリピプラゾールAPI市場規模を推定する際に考慮しました。

・アリピプラゾールAPI市場の概要
- 製品の定義
- アリピプラゾールAPIのタイプ別セグメント
- 世界のアリピプラゾールAPI市場規模：タイプ別分析（純度≧99%、純度＜99%）
- アリピプラゾールAPIの用途別セグメント
- 世界のアリピプラゾールAPI市場規模：用途別分析（錠剤、内服液、ODT、その他）
- 世界のアリピプラゾールAPI市場規模予測（2018年-2029年）
- アリピプラゾールAPIの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- アリピプラゾールAPI市場の競争状況およびトレンド

・アリピプラゾールAPIの地域別市場規模
- 北米のアリピプラゾールAPI市場規模（2018年-2029年）
- アメリカのアリピプラゾールAPI市場規模（2018年-2029年）
- ヨーロッパのアリピプラゾールAPI市場規模（2018年-2029年）
- アジア太平洋のアリピプラゾールAPI市場規模（2018年-2029年）
- 中国のアリピプラゾールAPI市場規模（2018年-2029年）
- 日本のアリピプラゾールAPI市場規模（2018年-2029年）
- 韓国のアリピプラゾールAPI市場規模（2018年-2029年）
- インドのアリピプラゾールAPI市場規模（2018年-2029年）
- オーストラリアのアリピプラゾールAPI市場規模（2018年-2029年）
- 中南米のアリピプラゾールAPI市場規模（2018年-2029年）
- 中東・アフリカのアリピプラゾールAPI市場規模（2018年-2029年）

・タイプ別セグメント：純度≧99%、純度＜99%
- 世界のアリピプラゾールAPIのタイプ別販売量（2018年-2023年）
- 世界のアリピプラゾールAPIのタイプ別売上（2018年-2023年）
- 世界のアリピプラゾールAPIのタイプ別価格

・用途別セグメント：錠剤、内服液、ODT、その他
- 世界のアリピプラゾールAPIの用途別販売量（2018年-2023年）
- 世界のアリピプラゾールAPIの用途別売上（2018年-2023年）
- 世界のアリピプラゾールAPIの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Teva、APOTEX、SMS Pharmaceutical、Otsuka Pharmaceutical、Bal Pharma、Huahai Pharmaceutical、Jiuzhou Pharmaceutical、Qilu Pharmaceutical、Yangtze River Pharmaceutical、Kanghong Pharmaceutical、Yongtai Pharmaceutical

・産業チェーンと販売チャネルの分析
- アリピプラゾールAPI産業チェーン分析
- アリピプラゾールAPIの主要原材料
- アリピプラゾールAPIの販売チャネル
- アリピプラゾールAPIのディストリビューター
- アリピプラゾールAPIの主要顧客

・アリピプラゾールAPI市場ダイナミクス
- アリピプラゾールAPIの業界動向
- アリピプラゾールAPI市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Aripiprazole API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Aripiprazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Aripiprazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Aripiprazole API include Teva, APOTEX, SMS Pharmaceutical, Otsuka Pharmaceutical, Bal Pharma, Huahai Pharmaceutical, Jiuzhou Pharmaceutical, Qilu Pharmaceutical and Yangtze River Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aripiprazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aripiprazole API.
The Aripiprazole API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aripiprazole API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aripiprazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Teva
APOTEX
SMS Pharmaceutical
Otsuka Pharmaceutical
Bal Pharma
Huahai Pharmaceutical
Jiuzhou Pharmaceutical
Qilu Pharmaceutical
Yangtze River Pharmaceutical
Kanghong Pharmaceutical
Yongtai Pharmaceutical
Segment by Type
Purity ≥ 99%
Purity ＜99%
Segment by Application
Tablets
Oral Solution
ODT
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aripiprazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aripiprazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Aripiprazole API Market Overview
1.1 Product Overview and Scope of Aripiprazole API
1.2 Aripiprazole API Segment by Type
1.2.1 Global Aripiprazole API Market Value Comparison by Type (2023-2029)
1.2.2 Purity ≥ 99%
1.2.3 Purity ＜99%
1.3 Aripiprazole API Segment by Application
1.3.1 Global Aripiprazole API Market Value by Application: (2023-2029)
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 ODT
1.3.5 Others
1.4 Global Aripiprazole API Market Size Estimates and Forecasts
1.4.1 Global Aripiprazole API Revenue 2018-2029
1.4.2 Global Aripiprazole API Sales 2018-2029
1.4.3 Global Aripiprazole API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aripiprazole API Market Competition by Manufacturers
2.1 Global Aripiprazole API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aripiprazole API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aripiprazole API Average Price by Manufacturers (2018-2023)
2.4 Global Aripiprazole API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Aripiprazole API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aripiprazole API, Product Type & Application
2.7 Aripiprazole API Market Competitive Situation and Trends
2.7.1 Aripiprazole API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aripiprazole API Players Market Share by Revenue
2.7.3 Global Aripiprazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aripiprazole API Retrospective Market Scenario by Region
3.1 Global Aripiprazole API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aripiprazole API Global Aripiprazole API Sales by Region: 2018-2029
3.2.1 Global Aripiprazole API Sales by Region: 2018-2023
3.2.2 Global Aripiprazole API Sales by Region: 2024-2029
3.3 Global Aripiprazole API Global Aripiprazole API Revenue by Region: 2018-2029
3.3.1 Global Aripiprazole API Revenue by Region: 2018-2023
3.3.2 Global Aripiprazole API Revenue by Region: 2024-2029
3.4 North America Aripiprazole API Market Facts & Figures by Country
3.4.1 North America Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aripiprazole API Sales by Country (2018-2029)
3.4.3 North America Aripiprazole API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aripiprazole API Market Facts & Figures by Country
3.5.1 Europe Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aripiprazole API Sales by Country (2018-2029)
3.5.3 Europe Aripiprazole API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aripiprazole API Market Facts & Figures by Country
3.6.1 Asia Pacific Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aripiprazole API Sales by Country (2018-2029)
3.6.3 Asia Pacific Aripiprazole API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aripiprazole API Market Facts & Figures by Country
3.7.1 Latin America Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aripiprazole API Sales by Country (2018-2029)
3.7.3 Latin America Aripiprazole API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aripiprazole API Market Facts & Figures by Country
3.8.1 Middle East and Africa Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aripiprazole API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aripiprazole API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aripiprazole API Sales by Type (2018-2029)
4.1.1 Global Aripiprazole API Sales by Type (2018-2023)
4.1.2 Global Aripiprazole API Sales by Type (2024-2029)
4.1.3 Global Aripiprazole API Sales Market Share by Type (2018-2029)
4.2 Global Aripiprazole API Revenue by Type (2018-2029)
4.2.1 Global Aripiprazole API Revenue by Type (2018-2023)
4.2.2 Global Aripiprazole API Revenue by Type (2024-2029)
4.2.3 Global Aripiprazole API Revenue Market Share by Type (2018-2029)
4.3 Global Aripiprazole API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aripiprazole API Sales by Application (2018-2029)
5.1.1 Global Aripiprazole API Sales by Application (2018-2023)
5.1.2 Global Aripiprazole API Sales by Application (2024-2029)
5.1.3 Global Aripiprazole API Sales Market Share by Application (2018-2029)
5.2 Global Aripiprazole API Revenue by Application (2018-2029)
5.2.1 Global Aripiprazole API Revenue by Application (2018-2023)
5.2.2 Global Aripiprazole API Revenue by Application (2024-2029)
5.2.3 Global Aripiprazole API Revenue Market Share by Application (2018-2029)
5.3 Global Aripiprazole API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Aripiprazole API Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 APOTEX
6.2.1 APOTEX Corporation Information
6.2.2 APOTEX Description and Business Overview
6.2.3 APOTEX Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 APOTEX Aripiprazole API Product Portfolio
6.2.5 APOTEX Recent Developments/Updates
6.3 SMS Pharmaceutical
6.3.1 SMS Pharmaceutical Corporation Information
6.3.2 SMS Pharmaceutical Description and Business Overview
6.3.3 SMS Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SMS Pharmaceutical Aripiprazole API Product Portfolio
6.3.5 SMS Pharmaceutical Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Corporation Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Otsuka Pharmaceutical Aripiprazole API Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Bal Pharma
6.5.1 Bal Pharma Corporation Information
6.5.2 Bal Pharma Description and Business Overview
6.5.3 Bal Pharma Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bal Pharma Aripiprazole API Product Portfolio
6.5.5 Bal Pharma Recent Developments/Updates
6.6 Huahai Pharmaceutical
6.6.1 Huahai Pharmaceutical Corporation Information
6.6.2 Huahai Pharmaceutical Description and Business Overview
6.6.3 Huahai Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Huahai Pharmaceutical Aripiprazole API Product Portfolio
6.6.5 Huahai Pharmaceutical Recent Developments/Updates
6.7 Jiuzhou Pharmaceutical
6.6.1 Jiuzhou Pharmaceutical Corporation Information
6.6.2 Jiuzhou Pharmaceutical Description and Business Overview
6.6.3 Jiuzhou Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiuzhou Pharmaceutical Aripiprazole API Product Portfolio
6.7.5 Jiuzhou Pharmaceutical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Qilu Pharmaceutical Aripiprazole API Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Yangtze River Pharmaceutical
6.9.1 Yangtze River Pharmaceutical Corporation Information
6.9.2 Yangtze River Pharmaceutical Description and Business Overview
6.9.3 Yangtze River Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Yangtze River Pharmaceutical Aripiprazole API Product Portfolio
6.9.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.10 Kanghong Pharmaceutical
6.10.1 Kanghong Pharmaceutical Corporation Information
6.10.2 Kanghong Pharmaceutical Description and Business Overview
6.10.3 Kanghong Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Kanghong Pharmaceutical Aripiprazole API Product Portfolio
6.10.5 Kanghong Pharmaceutical Recent Developments/Updates
6.11 Yongtai Pharmaceutical
6.11.1 Yongtai Pharmaceutical Corporation Information
6.11.2 Yongtai Pharmaceutical Aripiprazole API Description and Business Overview
6.11.3 Yongtai Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yongtai Pharmaceutical Aripiprazole API Product Portfolio
6.11.5 Yongtai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aripiprazole API Industry Chain Analysis
7.2 Aripiprazole API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aripiprazole API Production Mode & Process
7.4 Aripiprazole API Sales and Marketing
7.4.1 Aripiprazole API Sales Channels
7.4.2 Aripiprazole API Distributors
7.5 Aripiprazole API Customers
8 Aripiprazole API Market Dynamics
8.1 Aripiprazole API Industry Trends
8.2 Aripiprazole API Market Drivers
8.3 Aripiprazole API Market Challenges
8.4 Aripiprazole API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アリピプラゾールAPIのグローバル市場2023年：純度≧99%、純度＜99%(Global Aripiprazole API Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のアリピプラゾール経口液市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアリピプラゾール錠市場2023年：企業・地域・タイプ・用途別分析
  • 抗てんかん薬中間体のグローバル市場2023年：3,4,5-トリメトキシベンズアルデヒド、フェニル酢酸、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆